Bryan Dunyak

Bryan Dunyak is Director of Biomolecular Sciences & Lead Discovery at Remix Therapeutics, where he drives early-stage discovery programs targeting RNA–protein complexes. A chemical biologist with more than a decade of multidisciplinary experience across academia and industry, Bryan specializes in biochemistry, biophysics, and translational discovery for protein conformational diseases and protein–protein interactions. He excels at leading interdisciplinary teams through hit-to-lead and lead optimisation. At the Summit, Bryan will share insights on adapting biophysics for the RNA–protein interface to tackle large, dynamic RNP assemblies in drug discovery.